There is almost endless potential to AI in ophthalmology, but it will never replace human judgement

Sitting Down With… Robert MacLaren, Vitreoretinal Surgeon, Professor of Ophthalmology, University of Oxford, UK

DED management often relies on cyclosporin, but side effects can be problematic. A better vehicle for the active ingredient could be the answer

Anxious patients are 12.4 times more likely to experience pain during cataract surgery

Could harnessing the power of artificial intelligence put an end to the leading cause of sight loss in the developed world?

Introducing the winner of the ICO-Allergan Advanced Research Fellowship 2019

How second-generation devices ease concerns and simplify adoption

Will the VF test remain stuck in the last century while virtual reality and eye-tracking technology race ahead in this one?

Let’s talk about future clinical management of patients with vision problems – now!

Study of DNA methylation patterns in the RPE of AMD patients identifies three targets for drug development